Karande; Pankaj

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karande; Pankaj.The latest application filed is for "resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions".

Company Profile

1.10.16

Karande; Pankaj - Troy NY
Karande; Pankaj - Boston MA
Karande; Pankaj - Somerville MA
Karande, Pankaj - Goleta CA
Karande, Pankaj - Santa Barbara CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Resiquimod Topical And Injectable Compositions For The Treatment Of Neoplastic Skin Conditions App 20220096459 - Xu; Xiaowei ; et al.	2022-03-31
Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions Grant 11,179,385 - Xu , et al. November 23, 2	2021-11-23
Peptide Inhibitors Of Calcium Oxalate Monohydrate Crystallization And Uses Thereof App 20190153035 - Rimer; Jeffrey D. ; et al.	2019-05-23
Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof Grant 10,246,489 - Rimer , et al.	2019-04-02
Resiquimod Topical And Injectable Compositions For The Treatment Of Neoplastic Skin Conditions App 20180185350 - Xu; Xiaowei ; et al.	2018-07-05
Peptide Inhibitors Of Calcium Oxalate Monohydrate Crystallization And Uses Thereof App 20170283459 - Rimer; Jeffrey D. ; et al.	2017-10-05
Topical Formulations App 20170216314 - Kisak; Edward T. ; et al.	2017-08-03
Topical formulations for treating skin conditions Grant 9,642,912 - Kisak , et al. May 9, 2	2017-05-09
Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof Grant 9,617,306 - Rimer , et al. April 11, 2	2017-04-11
Topical formulations, systems and methods Grant 9,308,181 - Kisak , et al. April 12, 2	2016-04-12
Topical Formulations For Treating Skin Conditions App 20150297723 - Kisak; Edward T. ; et al.	2015-10-22
Peptide Inhibitors of Calcium Oxalate Monohydrate Crystallization and Uses Thereof App 20150099704 - Rimer; Jeffrey D. ; et al.	2015-04-09
Topical Formulations, Systems And Methods App 20130337031 - Kisak; Edward T. ; et al.	2013-12-19
Topical formulation Grant 8,513,304 - Kisak , et al. August 20, 2	2013-08-20
Topical Formulation App 20130079404 - Kisak; Edward T. ; et al.	2013-03-28
Topical formulation Grant 8,343,962 - Kisak , et al. January 1, 2	2013-01-01
Topical Formulation App 20110028460 - Kisak; Edward T. ; et al.	2011-02-03
Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof Grant 7,795,309 - Kisak , et al. September 14, 2	2010-09-14
Topical Formulation App 20100029769 - Kisak; Edward T. ; et al.	2010-02-04
Molecules to Enhance Percutaneous Delivery and Methods for Discovery Therefor App 20090105260 - Mitragotri; Samir ; et al.	2009-04-23
Topical Formulation App 20080221212 - Kisak; Edward T. ; et al.	2008-09-11
Distributed drug dispensing matrix as a transdermal patch App 20050181029 - Mitragotri, Samir ; et al.	2005-08-18
Combinatorial method for rapid screening of drug delivery formulations App 20040023841 - Mitragotri, Samir ; et al.	2004-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.